Cargando…
The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies
BACKGROUND: As the technology of next generation sequencing rapidly develops and costs are constantly reduced, the clinical availability of whole genome sequencing (WGS) increases. Thereby, it remains unclear what exact advantage WGS offers in comparison to whole exome sequencing (WES) for the diagn...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178799/ https://www.ncbi.nlm.nih.gov/pubmed/36785910 http://dx.doi.org/10.1002/mgg3.2148 |